Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Poster Abstracts from the Fourth International Symposium on Gait and Balance in Multiple Sclerosis: The Role of CognitionCleveland Clinic • Cleveland, Ohio, USA • October 10 & 11, 2014.
Ecological validity of walking capacity tests in multiple sclerosis.
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression.
Volumetric MRI assessment of brain and spinal cord in finnish twins discordant for multiple sclerosis.
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications.
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Multiple sclerosis.
Neuroimmunology: Aquaporin-4-antibody-seronegative neuromyelitis optica is less common than previously thought.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS.
Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes.
Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin.
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Pivotal role of choline metabolites in remyelination.
Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.
Improving communication with multiple sclerosis patients.
Chronic cerebrospinal venous insufficiency: pitfalls and perils of sonographic assessment.
Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly receiving selective serotonin-reuptake inhibitors.
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.

Pages